|
|
Post by prcgorman2 on Jan 13, 2020 21:52:10 GMT -5
Didn’t Mannkind hire someone from Amgen recently as in the last couple of months?
|
|
|
|
Post by kuka on Jan 13, 2020 22:02:44 GMT -5
i sense sarcasm ....but google what I told you before and you will understand what Hooper does now. I will remember your name so I can Hollar you in a few months.
|
|
|
|
Post by prcgorman2 on Jan 13, 2020 22:06:33 GMT -5
No sarcasm. I took what you said at face value and just assumed time will tell one way or the other. I thought what you said was plausible, and I thought I saw a post where someone from Amgen was hired. I thought it was interesting because Dr. Castagna came from there so I assumed it was someone with whom MC had a previous good working relationship. Ah, was it a recent add to the Board of Directors maybe?
|
|
|
|
Post by mnkdfann on Jan 13, 2020 22:08:33 GMT -5
No sarcasm. I took what you said at face value and just assumed time will tell one way or the other. I thought what you said was plausible, and I thought I saw a post where someone from Amgen was hired. I thought it was interesting because Dr. Castagna came from there so I assumed it was someone with whom MC had a previous good working relationship. Ah, was it a recent add to the Board of Directors maybe?Yes, it was the same Tony Hooper. (He sits on 3 Boards, last I heard.) investors.mannkindcorp.com/news-releases/news-release-details/mannkind-appoints-tony-hooper-its-board-directors |
|
|
|
Post by prcgorman2 on Jan 13, 2020 22:11:00 GMT -5
|
|
|
|
Post by kuka on Jan 13, 2020 22:20:46 GMT -5
|
|
|
|
Post by mnkdfann on Jan 13, 2020 22:37:09 GMT -5
|
|
|
|
Post by kuka on Jan 13, 2020 22:47:34 GMT -5
|
|
|
|
Post by mnkdfann on Jan 13, 2020 22:50:38 GMT -5
Is it possible that Hooper is finally leaving Amgen? The announcement below made it sound as though he was only staying on there for a limited while. Perhaps his leaving now is why he suddenly joined two Board of Directors recently. www.amgen.com/media/news-releases/2018/07/amgen-announces-succession-plans-for-two-executive-officers/THOUSAND OAKS, Calif., July 26, 2018 /PRNewswire/ In September 2018, Anthony C. Hooper, currently executive vice president of Global Commercial Operations, will retire from this role. Murdo Gordon, chief commercial officer of Bristol-Myers Squibb Company, has been named as executive vice president of Global Commercial Operations, effective Sept. 3, 2018. Gordon will report to Bradway. Hooper will also remain at Amgen for a period of time to facilitate the transition to Gordon. |
|
|
|
Post by kuka on Jan 13, 2020 22:58:07 GMT -5
|
|
|
|
Post by mnkdfann on Jan 13, 2020 23:03:43 GMT -5
Yeah, but that's a very old document from circa 2013, is it not? It appears to be, given the dates and content etc.
My question is whether he has now left Amgen. Some on-line evidence suggests as much.
|
|
|
|
Post by kuka on Jan 13, 2020 23:05:06 GMT -5
my point is that every company board that Hooper is put on gets bought out .....
|
|
|
|
Post by mnkdfann on Jan 13, 2020 23:19:53 GMT -5
my point is that every company board that Hooper is put on gets bought out ..... Okay, I get it now. If news leaked and MNKD is rising because of a buyout, hmmm. From what I can find online, it appears both ONYX and Beigene got a 30% to 35% pop when AMGEN bought out / took a stake. Since January 3, MNKD ran from 1.25 to 1.62. A pop of 29.6%. How much more room to run? Guess we'll see. |
|
|
|
Post by awesomo on Jan 13, 2020 23:29:25 GMT -5
So if Amgen buys out MannKind at $2-$3 a share (realistic premium given current PPS), would people be cool with that?
|
|
|
|
Post by nylefty on Jan 13, 2020 23:57:51 GMT -5
So if Amgen buys out MannKind at $2-$3 a share (realistic premium given current PPS), would people be cool with that? Absolutely not! |
|
